Published online before print October 30, 2006, doi: 10.1161/CIRCULATIONAHA.106.627489
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2006;114:2026-2033.)
© 2006 American Heart Association, Inc.
Genetics |
Compound Heterozygous Mutations P336L and I1660V in the Human Cardiac Sodium Channel Associated With the Brugada Syndrome
From Masonic Medical Research Laboratory (J.M.C., K.H., E.B., R.P., A.-M.O., Y.S., D.H., C.A.), Utica, NY; South University Center (CUSUR) and University of Guadalajara (CIBO-CUCS; H.B.-M.), Ciudad Guzmán, Jalisco, Mexico; Arrhythmia Unit, Hospital Clinic Barcelona (J.B.), Barcelona, Spain; Cardiovascular Research and Teaching Institute of Aalst (P.B.), Aalst, Belgium; Department of Physiology and Biophysics (R.D.), Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, Quebec, Canada; and Montreal Heart Institute (R.B.), Montreal, Quebec, Canada. Dr Hong is currently with the Cardiology Section, Second Hospital, Nanchang University, Nanchang, China.
Correspondence to Jonathan M. Cordeiro, PhD, Department of Experimental Cardiology, Masonic Medical Research Laboratory, 2150 Bleecker St, Utica, NY 13501. E-mail jcordeiro{at}mmrl.edu
Received March 16, 2006; revision received September 5, 2006; accepted September 8, 2006.
Background— Loss-of-function mutations in SCN5A have been associated with the Brugada syndrome. We report the first Brugada syndrome family with compound heterozygous mutations in SCN5A. The proband inherited 1 mutation from each parent and transmitted 1 to each daughter.
Methods and Results— The effects of the mutations on the function of the sodium channel were evaluated with heterologous expression in TSA201 cells, patch-clamp study, and confocal microscopy. Genetic analysis revealed that the proband carried 2 heterozygous missense mutations (P336L and I1660V) on separate alleles. He displayed a coved-type ST-segment elevation and a prolonged PR interval (280 ms). One daughter inherited P336L and exhibited a prolonged PR (210 ms). The other daughter inherited mutation I1660V and displayed a normal PR interval. Both daughters had a slightly elevated, upsloping ST-segment elevation. The parents had normal ECGs. Patch-clamp analysis showed that the P336L mutation reduced INa by 85% relative to wild type. The I1660V mutation produced little measurable current, which was rescued by room temperature incubation for 48 hours. Sodium channel blockers also rescued the I1660V current, with mexiletine proving to be the most effective. Confocal immunofluorescence showed that I1660V channels conjugated to green fluorescent protein remained trapped in intracellular organelles.
Conclusions— Mutation P336L produced a reduction in cardiac INa, whereas I1660V abolished it. Only the proband carrying both mutations displayed the Brugada syndrome phenotype, whereas neither mutation alone produced the clinical phenotype. I1660V channels could be rescued pharmacologically and by incubation at room temperature. The present data highlight the role of compound heterozygosity in modulating the phenotypic expression and penetrance of Brugada syndrome.
CLINICAL PERSPECTIVE
This article has been cited by other articles:
 |
|
 |
|
  T. Horishita and R. A. Harris n-Alcohols Inhibit Voltage-Gated Na+ Channels Expressed in Xenopus Oocytes J. Pharmacol. Exp. Ther., July 1, 2008; 326(1): 270 - 277. [Abstract] [Full Text] [PDF]
|
|